Landscapes / Targets

FGFR2

11 drugs act on FGFR2, in 17 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs11

DrugHow it worksCompanyStageNext dateDetails
Tyrosine kinase inhibitor
Approved Sep 2027Phase 2 trial completes
Infigratinibnot checked
Tyrosine kinase inhibitor
Phase 2/3 Jan 2027Phase 2/3 trial completes
—
Phase 1/2 Mar 2027Phase 1/2 trial completes
—
Phase 2 Dec 2027Phase 2 trial completes
—
Phase 1/2 16 Jun 2028Phase 1/2 trial completes
—
Phase 2 15 Dec 2028Phase 1/2 trial completes
—
Phase 1 31 Dec 2026Phase 1 trial completes
—
Huadong Medicine · Public 000963.SZ
Phase 1 31 Jan 2027Phase 1 trial completes
—
Phase 1 Mar 2027Phase 1 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes
—
AstraZeneca +1
Phase 1 —

About this list

Checked
10 of 11 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow FGFR2

Following is part of Solo: you see every change to FGFR2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in